NCT06195709 2026-04-17
ECLECTIC
Institut Curie
Phase 3 Recruiting
Clinical Trials
4 trialsNCT07528898 2026-04-14
Neoadjuvant SHR-A1811 Combined With Pertuzumab in HER2-Positive Breast Cancer: An Exploratory Clinical Study.
Hebei Medical University Fourth Hospital
Phase 2 Not yet recruiting
NCT04943497 2026-04-01
PROSPERITY
Novartis
Completed
NCT05143970 2026-03-20
CHANCES
Institut Paoli-Calmettes
Phase 1 Recruiting